Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab effects on arterial inflammation and stiffness in active rheumatoid arthritis
NL-OMON40306Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Feb 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of tocilizumab in rheumatoid arthritis (RA), sponsored by University Medical Center Groningen. Primary endpoint: Arterial stiffness by pulse wave velocity. Started Feb 2015; status: active, not recruiting.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON40306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40306.